Fluicell Overview
- Founded
-
2012
- Status
-
Public
- Employees
-
19
- Stock Symbol
-
FLUI
- Share Price
-
$0.72
- (As of Thursday Closing)
Fluicell General Information
Description
Fluicell AB is a provider of high resolution SINGLE-CELL DISCOVERY PLATFORMS for biomedicine, drug development, and bioprinting. The company's products include Biopen, Dynaflow.
Contact Information
Website
www.fluicell.com
Formerly Known As
Avalance Biotech
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
STO
Primary Office
- Flojelbergsgatan 8c
- 431 37 Molndal
- Sweden
+46 076-208 00 00
Fluicell Timeline
Fluicell Stock Performance
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.72 | $0.69 | $0.64 - $3.97 | $9.6M | 13.3M | 40.8K | -$0.20 |
Fluicell Financials Summary
|
In Thousands, USD |
TTM 31-Mar-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|---|
| EV | 15,979 | 26,052 | 27,614 | 6,091 |
| Revenue | 322 | 303 | 503 | 263 |
| EBITDA | (2,342) | (2,458) | (1,781) | (1,920) |
| Net Income | (2,406) | (2,526) | (1,908) | (1,970) |
| Total Assets | 2,306 | 2,981 | 3,027 | 2,132 |
| Total Debt | 0 | 0 | 0 | 535 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Fluicell Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Fluicell Patents
Fluicell Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20200165554-A1 | Methods and systems utilizing recirculating fluid flows | Pending | 28-Jul-2017 | 000000000 | |
| EP-3658199-A1 | Methods and systems utilizing recirculating fluid flows | Withdrawn | 28-Jul-2017 | 000000000 | |
| US-9658240-B2 | Microfluidic device with holding interface, and methods of use | Active | 06-May-2011 | 00000000000 | 00 |
| US-20140147930-A1 | Microfluidic device with holding interface, and methods of use | Granted | 06-May-2011 | 0000000000 | 0 |
| EP-3885045-A1 | Microfluidic device with holding interface, and method of use | Pending | 06-May-2011 | B01L3/0255 | 0 |
Fluicell Executive Team (9)
Fluicell Board Members (9)
| Name | Representing | Role | Since |
|---|---|---|---|
| Aldo Jesroka | Fluicell | Scientific Advisor, Board Member & Co-Founder | 000 0000 |
| Carl Fhager | Self | Board Member | 000 0000 |
| Daniel Chiu | Fluicell | Board Member | 000 0000 |
| Gavin Jeffries Ph.D | Fluicell | Chief Technology Officer, Board Member & Co-Founder | 000 0000 |
| Owe Orwar | Self | Board Member | 000 0000 |
Fluicell Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Fluicell Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|